An open-label, multicentre, randomised phase 2 study of recombinant human granulocyte colony-stimulating factor (filgrastim) as an adjunct to combination chemotherapy in paediatric patients with metastatic neuroblastoma-Reference-Cited by-同舟云学术

An open-label, multicentre, randomised phase 2 study of recombinant human granulocyte colony-stimulating factor (filgrastim) as an adjunct to combination chemotherapy in paediatric patients with metastatic neuroblastoma

Published:1998-06 Issue:7 Volume:34 Page:1063-1069
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Michon J.M,Hartmann O,Bouffet E,Meresse V,Coze C,Rubie H,Bordigoni P,Cattiaux E,Ward N,Bernard J.-L,Lemerle J,Zucker J.-M,Philip T

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference20 articles.

1. Where next with therapy in advanced neuroblastoma?;Pinkerton;Br J Cancer,1990

2. Advanced neuroblastoma improved response rate using a multiagent regimen (OPEC) including sequential cisplatin and VM26;Shafford;J Clin Oncol,1984

3. Bernard JL, Philip T, Zucker JM, et al. Sequential cisplatin VM26 and vincristine-cyclophosphamide–doxorubicin in metastatic neuroblastoma. An effective alternating non-cross resistant regimen? J Clin Oncol 1987, 5, 1952–1959.

4. Pinkerton CR, Zucker JM, Hartmann O, et al. Short duration, high dose intensity induction chemotherapy in advanced neuroblastoma. Is there any therapeutic gain? Br J Cancer 1990, 62, 319–323.

5. Philip T, Zucker JM, Bernard JL, et al. Improved survival at 2 and 5 years in the LMCE 1 unselected group of 72 children with stage IV neuroblastoma older than 1 year of age at diagnosis: is cure possible in a small subgroup? J Clin Oncol 1991, 9, 1037–1044.

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emergency management of fever and neutropenia in children with cancer: A review;The American Journal of Emergency Medicine;2021-12

2. Efficacy and Safety of Filgrastim and Its Biosimilars to Prevent Febrile Neutropenia in Cancer Patients: A Prospective Study and Meta-Analysis;Biology;2021-10-19

3. Is high‐risk neuroblastoma induction chemotherapy possible without G‐CSF? A pilot study of safety and treatment delays in the absence of primary prophylactic hematopoietic growth factors;Pediatric Blood & Cancer;2020-07-30

4. Efficacy and tolerability of granulocyte colony-stimulating factors in cancer patients after chemotherapy: A systematic review and Bayesian network meta-analysis;Scientific Reports;2019-10-25

5. Prophylactic antibiotics or G(M)-CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapy;Cochrane Database of Systematic Reviews;2015-12-21